Mr. Stephen Mulvany:

Or the sums. There are some drugs - I am speaking of an area about which Deputy O'Connell would know far more than I do - which might never meet those simple quality-adjusted life year, QALY, thresholds and the decisions about those get ever more difficult and challenging. We, the HSE leadership team, will at times approve based on recommendations from our drug committee. We can approve and have approved in the past drugs that go beyond the standard QALY thresholds for various reasons. No doubt the Minister has capacity in this area as well.